Use of plasma brain natriuretic peptide concentration to aid in the diagnosis of heart failure

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Plasma concentration of brain natriuretic peptide (BNP), as measured by the Triage BNP Test, is approved by the Food and Drug Administration to aid in the diagnosis of heart failure. This diagnostic test is available in many institutions. The purpose of this article is to help the physician know the appropriate time to order this test and to aid in interpreting results. To achieve this goal, we review the physiology of BNP, clinical studies that support its use for diagnosing heart failure, and confounding variables to consider when BNP is being used clinically. We show that the BNP test can be extremely helpful when used in the correct clinical setting.

Original languageEnglish (US)
Pages (from-to)481-486
Number of pages6
JournalMayo Clinic Proceedings
Volume78
Issue number4
StatePublished - Apr 1 2003

Fingerprint

Brain Natriuretic Peptide
Heart Failure
Confounding Factors (Epidemiology)
Triage
United States Food and Drug Administration
Routine Diagnostic Tests
Physicians

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{a44dd05bb52949efa33b1132c5d18c93,
title = "Use of plasma brain natriuretic peptide concentration to aid in the diagnosis of heart failure",
abstract = "Plasma concentration of brain natriuretic peptide (BNP), as measured by the Triage BNP Test, is approved by the Food and Drug Administration to aid in the diagnosis of heart failure. This diagnostic test is available in many institutions. The purpose of this article is to help the physician know the appropriate time to order this test and to aid in interpreting results. To achieve this goal, we review the physiology of BNP, clinical studies that support its use for diagnosing heart failure, and confounding variables to consider when BNP is being used clinically. We show that the BNP test can be extremely helpful when used in the correct clinical setting.",
author = "Shapiro, {Brian P} and Chen, {Horng Haur} and Burnett, {John C Jr.} and Redfield, {Margaret May}",
year = "2003",
month = "4",
day = "1",
language = "English (US)",
volume = "78",
pages = "481--486",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "4",

}

TY - JOUR

T1 - Use of plasma brain natriuretic peptide concentration to aid in the diagnosis of heart failure

AU - Shapiro, Brian P

AU - Chen, Horng Haur

AU - Burnett, John C Jr.

AU - Redfield, Margaret May

PY - 2003/4/1

Y1 - 2003/4/1

N2 - Plasma concentration of brain natriuretic peptide (BNP), as measured by the Triage BNP Test, is approved by the Food and Drug Administration to aid in the diagnosis of heart failure. This diagnostic test is available in many institutions. The purpose of this article is to help the physician know the appropriate time to order this test and to aid in interpreting results. To achieve this goal, we review the physiology of BNP, clinical studies that support its use for diagnosing heart failure, and confounding variables to consider when BNP is being used clinically. We show that the BNP test can be extremely helpful when used in the correct clinical setting.

AB - Plasma concentration of brain natriuretic peptide (BNP), as measured by the Triage BNP Test, is approved by the Food and Drug Administration to aid in the diagnosis of heart failure. This diagnostic test is available in many institutions. The purpose of this article is to help the physician know the appropriate time to order this test and to aid in interpreting results. To achieve this goal, we review the physiology of BNP, clinical studies that support its use for diagnosing heart failure, and confounding variables to consider when BNP is being used clinically. We show that the BNP test can be extremely helpful when used in the correct clinical setting.

UR - http://www.scopus.com/inward/record.url?scp=0037381602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037381602&partnerID=8YFLogxK

M3 - Article

C2 - 12683700

AN - SCOPUS:0037381602

VL - 78

SP - 481

EP - 486

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 4

ER -